Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.2.1.21 - beta-glucosidase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Aberrant Crypt Foci
Transgenic alfalfa that accumulates piceid (trans-resveratrol-3-O-beta-D-glucopyranoside) requires the presence of beta-glucosidase to inhibit the formation of aberrant crypt foci in the colon of CF-1 mice.
Adenocarcinoma
Alteration in glycosidases from well-differentiated colorectal adenocarcinoma of rat.
adenylate cyclase deficiency
Enzymatic alterations secondary to adenyl cyclase deficiency in the cr-1 (crisp) mutant of Neurospora crassa: anomalies of the beta-glucosidase system.
Agranulocytosis
Pharmacologic manipulation of the murine pulmonary biochemical response to NO2.
Albuminuria
Progression of chronic adriamycin nephropathy in leukopenic rats.
alpha-galactosidase deficiency
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Anemia
Gaucher disease type 1: the first experience of enzyme replacement therapy in pediatric practice in Moldova - case report.
[Guidelines for type 1 Gaucher's disease].
Arthritis
Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora?
Arthritis, Juvenile
Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora?
arylsulfatase (type i) deficiency
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
beta-galactosidase deficiency
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
beta-glucosidase deficiency
An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency.
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Progressive myoclonic epilepsy due to Gaucher's disease in an adult.
[Adult-type Gaucher's disease: an histochemical study of one case (author's transl)]
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Brucellosis
[Immunogenic properties of emulsin vaccine against paratyphoid and brucellosis in sheep]
Carcinogenesis
Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats.
Effects of apple pectin on fecal bacterial enzymes in azoxymethane-induced rat colon carcinogenesis.
Effects of differing purified cellulose, pectin, and hemicellulose fiber diets on fecal enzymes in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Carcinoma
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Carcinoma, Hepatocellular
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
Carcinoma, Lewis Lung
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Central Nervous System Diseases
Effectors of three beta-glucosidases from human liver.
Coccidioidomycosis
A seroreactive 120-kilodalton beta-1,3-glucanase of Coccidioides immitis which may participate in spherule morphogenesis.
Colitis
T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model.
Colonic Neoplasms
Possible contribution of beta-glucosidase and caspases in the cytotoxicity of glufosfamide in colon cancer cells.
The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon.
Colorectal Neoplasms
Characterization of beta-glucosidase and beta-glucuronidase of alkalotolerant intestinal bacteria.
Coronary Disease
[The use of biochemical indices in the prognosis and diagnosis of ischemic heart disease]
Cystic Fibrosis
Acid hydrolases in sera and plasma from patients with cystic fibrosis.
Dementia
Wild-type GBA1 increases the ?-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Dermatitis, Exfoliative
Lysosomal hydrolases of the epidermis. 6. Changes in disease.
Diabetes Mellitus, Type 2
A TLC bioautographic method for the detection of alpha- and beta-glucosidase inhibitors in plant extracts.
Dry Eye Syndromes
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease.
Enterocolitis, Necrotizing
Serum cytosolic beta-glucosidase activity in a rat model of necrotizing enterocolitis.
Epilepsies, Myoclonic
Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme.
Favism
Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.
Food Hypersensitivity
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy.
Gangliosidosis, GM1
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
Multiple carbohydrate-cleaving specificities in human acidic and neutral glycosidases.
Gaucher Disease
A flow cytometric assay for lysosomal glucocerebrosidase.
A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Accurate Molecular Diagnosis of Gaucher Disease Using Clinical Exome Sequencing as a First-Tier Test.
Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.
Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease.
Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
Assay of the beta-glucosidase activity with natural labelled and artificial substrates in cultivated skin fibroblasts from homozygotes and heterozygotes with the Norrbottnian type of Gaucher disease.
Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
Assessment of cellular cobalamin metabolism in Gaucher disease.
Beta-glucosidase activities in human tissues. Findings in Gaucher's disease.
beta-Glucosidase activities in the Norrbotten type of juvenile Gaucher's disease.
Beta-glucosidase activity as a diagnostic index of Gaucher's disease.
Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease.
Beta-glucosidase activity in liver, spleen and brain in acute neuropathic Gaucher disease.
beta-Glucosidase assays in the diagnosis of Gaucher's disease.
beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.
beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
beta-Glucoside hydrolase activity of normal and glucosylceramidotic cultured human skin fibroblasts.
Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.
Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.
Brain glucocerebrosidase in Gaucher's disease.
Canine Gaucher disease--the enzymic defect.
Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison with N-(n-nonyl)Deoxynojirimycin.
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.
Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.
Chronic Gaucher's disease: radiological findings in 17 South African cases.
Clinical and enzyme studies in Gaucher disease.
Clinical variation in 2 related children with neuronopathic Gaucher disease.
Communicating hydrocephalus in a patient with Gaucher's disease type 3.
Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease.
Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene".
Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease.
Deficiency of steriod beta-glucosidase in Gaucher disease.
Diagnosing sphingolipidoses in murine and human embryos.
Diagnosis of Gaucher's disease in cultured skin fibroblasts and leucocytes.
Effectors of three beta-glucosidases from human liver.
Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
Elevation of serum beta-hexosaminidase and alpha-D-mannosidase in type 2 Gaucher disease: a clinical and biochemical study.
Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease.
Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages.
Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy.
Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation.
Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
Gaucher's disease type I. Report of a case with prominent deposition of ceroid in splenic endothelial cells and intestinal smooth muscle fibers.
Gaucher's disease.
Gaucher's disease. I. Modern enzymatic and anatomic methods of diagnosis.
Gaucher's disease. I. Solubilization and electrophoresis of beta-glucosidase from leukocytes and cultured fibroblasts.
Gaucher's disease: past, present and future.
Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
Genetic heterogeneity of membrane-bound beta-glucosidase in Gaucher's disease.
Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease.
Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity.
Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
Heterozygote detection of type I Gaucher disease using blood platelets.
Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
Identification of a feedback loop involving beta-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.
Identity of beta-glucosidase, beta-xylosidase and one of the beta-galactosidase activities in human liver when assayed with 4-methylumbelliferyl-beta-D-glycosides studies in cases of Gaucher's disease.
Immunoquantification of beta-glucosidase: diagnosis and prediction of severity in Gaucher disease.
Imprint cytology of Gaucher's disease presenting as a splenic mass. A case report with molecular approaches.
In utero diagnosis of Gaucher disease.
In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency.
Isozymes of beta-glucosidase: determination of Gaucher's disease phenotypes.
Leukocyte beta-glucosidase in a child with Gaucher's disease and his kinship.
Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
Lysosomal storage disorders.
Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.
Modifications of the molecular weight of membrane-bound nonspecific beta-glucosidase in type 1 Gaucher disease determined in situ by the radiation inactivation method.
Morphological and biochemical assessment of the cornea in a Gaucher disease carrier with keratoconus.
Multiple carbohydrate-cleaving specificities in human acidic and neutral glycosidases.
Multiple forms of beta-glucosidase in Gaucher disease.
Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
Multiple space-occupying lesions of the spleen in a case of Gaucher's disease.
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations.
Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease.
N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease.
Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
Physical and kinetic properties of beta-glucosidase in Gaucher disease.
Prenatal diagnosis of Gaucher disease. Assay of the beta-glucosidase activity in amniotic fluid cells cultivated in two laboratories with different cultivation conditions.
Prenatal diagnosis of Gaucher's disease type 2. Ultrasonographic, biochemical and histological aspects.
Progressive myoclonic epilepsy due to Gaucher's disease in an adult.
Properties of beta-glucosidase in cultured skin fibroblasts from controls and patients with Gaucher disease.
Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease.
Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
Skeletal complications of Gaucher disease.
Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes.
Some histochemical observations on Gaucher cells.
Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
Synthesis and use of novel fluorescent glycosphingolipids for estimating beta-glucosidase activity in vitro in the absence of detergents and subtyping Gaucher disease variants following administration into intact cells.
Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
The beta-glucosidase isozymes and the enzymatic defect in Gaucher disease.
The cytosolic beta-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation.
The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.
The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts.
The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.
Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Use of plain radiography to optimize skeletal outcomes in children with type 1 Gaucher disease in Brazil.
[Cavernoma complicated with biliopatia secondary to type 1 Gaucher disease: report of a Peruvian case].
[Enzyme replacement therapies for lysosomal storage disorders.]
[Gaucher disease]
[Gaucher's disease suspected by abdominal echography findings]
[Guidelines for type 1 Gaucher's disease].
[Laboratory diagnosis of Gaucher's disease. Value of leukocyte beta-glucosidase determination]
[Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)]
[Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease]
Glioblastoma
Cyanide bystander effect of the linamarase/linamarin killer-suicide gene therapy system.
Differential expression of the T-cell inhibitor TIGIT in glioblastoma and MS.
Glioma
Glioma Regression In vitro and In vivo by a Suicide Combined Treatment.
Glycogen Storage Disease Type II
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Graft vs Host Disease
Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT.
Hand, Foot and Mouth Disease
Antiviral activity of acid beta-glucosidase 1 on enterovirus 71, a causative agent of hand, foot and mouth disease.
Heart Failure
[Correction with cordaron of changes in beta-glucosidase activity induced by toxic effect of strophanthin K and simulated heart decompensation]
Herpes Zoster
Sperm require beta-N-acetylglucosaminidase to penetrate through the egg zona pellucida.
HIV Infections
A novel lectin from Pseudostellaria heterophylla roots with sequence simularity to Kunitz-type soybean trypsin inhibitor.
Hypogin, a novel antifungal peptide from peanuts with sequence similarity to peanut allergen.
Hydrops Fetalis
Prenatal diagnosis of Gaucher's disease type 2. Ultrasonographic, biochemical and histological aspects.
Hypersensitivity
Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.
Hyperthyroidism
Differential effect of hyperthyroidism on rat epididymal glycosidases.
Impact of altered thyroid hormone status on prostatic glycosidases.
Infections
A lectin-like wheat gene responds systemically to attempted feeding by avirulent first-instar Hessian fly larvae.
Characterization of cell wall degrading enzymes of Thanatephorus cucumeris.
Exoproteome Analysis of Human Pathogenic Dermatophyte Species and Identification of Immunoreactive Proteins.
Isolation and characterization of genes differentially expressed during the interaction between apple fruit and Penicillium expansum.
Lysosomal enzyme in Mastomys natalensis during Dipetalonema viteae infection.
Stagonospora avenae secretes multiple enzymes that hydrolyze oat leaf saponins.
Sucrose-induced lupine defense against Fusarium oxysporum. Sucrose-stimulated accumulation of isoflavonoids as a defense response of lupine to Fusarium oxysporum.
Inflammatory Bowel Diseases
Beta-glucuronidase and Beta-glucosidase activity in stool specimens of children with inflammatory bowel disease.
Keratitis, Herpetic
[Glycosidase activity of the tears in patients with ophthalmic herpes]
Leukemia
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
Leukodystrophy, Metachromatic
[Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)]
Lewy Body Disease
Wild-type GBA1 increases the ?-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Lipidoses
[Value of studying isoenzymes in hereditary lysosomal lipidoses. In particular beta-glucosidase (Gaucher's disease) and acid lipase (Wolman's disease and cholesterol ester storage disease)]
Lysosomal Storage Diseases
An in situ study of beta-glucosidase activity in normal and Gaucher fibroblasts with fluorogenic probes.
Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity.
Imprint cytology of Gaucher's disease presenting as a splenic mass. A case report with molecular approaches.
Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations.
Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility.
Use of plain radiography to optimize skeletal outcomes in children with type 1 Gaucher disease in Brazil.
[Screening methods for the diagnosis of lysosomal storage disease]
Malnutrition
Neonatal undernutrition and short term administration of hydrocortisone and thyroxine: effects on rat brain hydrolases.
Mannosidase Deficiency Diseases
Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity.
Melanoma
beta-Glucosidase activity in fetal bovine serum renders the plant glucoside, hypoxoside, cytotoxic toward B16-F10-BL-6 mouse melanoma cells.
Morphological characterisation of the cell-growth inhibitory activity of rooperol and pharmacokinetic aspects of hypoxoside as an oral prodrug for cancer therapy.
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Mesothelioma
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors.
Mesothelioma, Malignant
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors.
Mouth Diseases
Antiviral activity of acid beta-glucosidase 1 on enterovirus 71, a causative agent of hand, foot and mouth disease.
Mucolipidoses
Acid hydrolases in serum from patients with lysosomal disorders.
Evidence for the deficiency of beta-glucosidase-activating factor in fibroblasts of patients with I-cell disease.
Lysosomal enzymes in medium from cultured skin fibroblasts from normal individuals and patients with lysosomal diseases.
Mucopolysaccharidosis IV
An autophagic vacuolar myopathy-like disorder presenting as nonimmune hydrops in a female fetus.
Mycoses
Avenacosidase from oat: purification, sequence analysis and biochemical characterization of a new member of the BGA family of beta-glucosidases.
Novel type of enzyme multimerization enhances substrate affinity of oat beta-glucosidase.
Myeloproliferative Disorders
Platelet lysosomal enzymes are normal in myeloproliferative disorders.
Myocardial Infarction
Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats.
[Glycosphingolipid content and beta-galacto- and beta-glucosidase activity of the blood in acute myocardial infarction and postinfarction cardiosclerosis]
Myoclonic Epilepsies, Progressive
Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme.
Neoplasm Metastasis
Inhibition of experimental metastasis by an alpha-glucosidase inhibitor, 1,6-epi-cyclophellitol.
Neoplasms
Antitumor activity of amygdalin MF (NSC-15780) as a single agent and with beta-glucosidase (NSC-128056) on a spectrum of transplantable rodent tumors.
Antitumor activity of methyl (5-fluoro-1H-2-oxo-4-pyrimidinyl beta-D-glucopyranosid)uronate against various experimental tumors.
Cancer-preventing attributes of probiotics: an update.
Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis.
Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats.
Enzyme activity profiles in mouse teratocarcinomas. A quantitative ultramicroscale analysis.
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Glioma Regression In vitro and In vivo by a Suicide Combined Treatment.
Lactic acid bacteria as probiotics.
Lysosomal isozyme patterns in ethylnitrosourea-induced brain tumors.
Modulation of intestinal environment by prebiotic germinated barley foodstuff prevents chemo-induced colonic carcinogenesis in rats.
Successful use of a plant gene in the treatment of cancer in vivo.
Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
The case against laetrile: the fraudulent cancer remedy.
Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles.
[The canine model in the gene therapy of glioblastoma]
[Tumour hyperacidulation through intravenous glucose infusion enhanced by amygdalin and beta-glucosidase application (author's transl)]
Nephrotic Syndrome
Biochemical and molecular findings in a patient with myoclonic epilepsy due to a mistarget of the beta-glucosidase enzyme.
Neurologic Manifestations
The pharmacological chaperone effect of N-octyl-beta-valienamine on human mutant acid beta-glucosidases.
Niemann-Pick Diseases
Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher's and Niemann-Pick diseases.
Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates.
Osteosarcoma
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).
Parkinson Disease
Wild-type GBA1 increases the ?-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Periodontitis
Glycosidase activities in gingival crevicular fluid in subjects with adult periodontitis or gingivitis.
Plant Diseases
Partial purification and properties of a beta-glucosidase from Erwinia herbicola Y46.
Rhinitis, Allergic, Seasonal
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy.
Sarcoidosis
Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.
Sarcoma
Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.
Scabies
Deletion of bglC triggers a genetic compensation response by awakening the expression of alternative beta-glucosidase.
Scleroderma, Diffuse
Origin of the enhanced activity of lysosomal beta-galactosidase in serum and skin in progressive systemic sclerosis.
Sepsis
Lysosomal enzyme pattern in lung lymph and blood during E. coli sepsis in sheep.
Shock, Septic
Application of cross-linked carboxymethyl cellulose degradation by beta-glucosidase and vaginal microbes to toxic shock syndrome.
Sphingolipidoses
Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease.
N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease.
Starvation
A digestive beta-glucosidase from the silkworm, Bombyx mori: cDNA cloning, expression and enzymatic characterization.
Exo-(1----3)-beta-glucanase, autolysin and trehalase activities during yeast growth and germ-tube formation in Candida albicans.
Glycosyl hydrolases of cell wall are induced by sugar starvation in Arabidopsis.
Isolation of cDNA clones of genes with altered expression levels in phosphate-starved Brassica nigra suspension cells.
Stupor
[Tumour hyperacidulation through intravenous glucose infusion enhanced by amygdalin and beta-glucosidase application (author's transl)]
Thrombocytopenia
[Guidelines for type 1 Gaucher's disease].
Tuberculosis
[Evaluation of urease and beta-glucosidase activity for the practical identification of mycobacteria (author's transl)]
Uterine Cervical Neoplasms
Synthesis and biological activity of novel thiazolidin-4-ones with a carbohydrate moiety.
Vascular Diseases
Enzymes and cytomorphological sperm alterations in some diseases of the male reproductive system.
Wheat Hypersensitivity
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy.